Federation Des Caisses Desjardins Du Quebec Dare Bioscience, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Aug 30, 2024	SELL	$1.42 - $2.0 $5,680 - $8,000	-4,000 Closed	0 $0
Q2 2021 Aug 30, 2024	BUY	$1.21 - $1.89 $4,840 - $7,560	4,000 New	4,000 $7.56 Million
Q1 2021 Aug 30, 2024	SELL	$1.31 - $3.0 $1,965 - $4,500	-1,500 Reduced 23.08%	5,000 $8.45 Million
Q3 2020 Aug 30, 2024	BUY	$0.98 - $1.52 $6,370 - $9,880	6,500 New	6,500 $6.49 Million
Q2 2020 Aug 30, 2024	SELL	$0.84 - $1.11 $7,560 - $9,990	-9,000 Closed	0 $0
Q4 2019 Aug 30, 2024	BUY	$0.72 - $0.9 $6,480 - $8,100	9,000 New	9,000 $7.38 Million

Others Institutions Holding DARE

# of Institutions

Shares Held

267K

Call Options Held

Put Options Held

View Full List

About Dare Bioscience, Inc.

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $270M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

More about DARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account